Release Date: 16/08/16 08:52 Summary: Class FY16 Appendix 4E and Annual Report-CL1.AX Price Sensitive: Yes Download Document 2.08MB Download
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market